XiangDi Wang

475 total citations
24 papers, 369 citations indexed

About

XiangDi Wang is a scholar working on Molecular Biology, Ophthalmology and Organic Chemistry. According to data from OpenAlex, XiangDi Wang has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Ophthalmology and 6 papers in Organic Chemistry. Recurrent topics in XiangDi Wang's work include Retinal Development and Disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). XiangDi Wang is often cited by papers focused on Retinal Development and Disorders (5 papers), Retinal Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). XiangDi Wang collaborates with scholars based in United States, China and Egypt. XiangDi Wang's co-authors include Shin‐ichiro Yokoyama, Nobuyuki Takakura, Noboru Fukuda, Yoshihiro Yamada, Monica M. Jablonski, Eldon E. Geisert, TJ Hollingsworth, Sanjay R. Mishra, Jing Liu and Ying Zhang and has published in prestigious journals such as ACS Nano, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

XiangDi Wang

21 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
XiangDi Wang United States 10 139 125 104 74 62 24 369
Joanna Olkowska Poland 12 174 1.3× 135 1.1× 176 1.7× 67 0.9× 3 0.0× 18 427
Nicholas Watson United States 4 187 1.3× 42 0.3× 19 0.2× 37 0.5× 16 0.3× 4 338
Wei‐Chung Vivian Yang Taiwan 10 156 1.1× 69 0.6× 56 0.5× 38 0.5× 3 0.0× 14 436
Yiwei Qi China 10 202 1.5× 41 0.3× 32 0.3× 22 0.3× 3 0.0× 21 406
Joanna Stachura Poland 11 155 1.1× 14 0.1× 56 0.5× 9 0.1× 54 0.9× 21 417
Jiahui Kong China 8 119 0.9× 26 0.2× 51 0.5× 33 0.4× 80 1.3× 17 328
Qianqian Shan China 9 103 0.7× 13 0.1× 60 0.6× 17 0.2× 4 0.1× 19 313
Imke Rudnik‐Jansen Netherlands 13 143 1.0× 92 0.7× 6 0.1× 26 0.4× 7 0.1× 20 462

Countries citing papers authored by XiangDi Wang

Since Specialization
Citations

This map shows the geographic impact of XiangDi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by XiangDi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites XiangDi Wang more than expected).

Fields of papers citing papers by XiangDi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by XiangDi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by XiangDi Wang. The network helps show where XiangDi Wang may publish in the future.

Co-authorship network of co-authors of XiangDi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of XiangDi Wang. A scholar is included among the top collaborators of XiangDi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with XiangDi Wang. XiangDi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, XiangDi, et al.. (2025). Substrate‐Controlled [2 + 3] and [3 + 3] Annulation of Bisnucleophiles: Access to Oxygen Heterocycles. European Journal of Organic Chemistry. 28(22).
2.
Kim, Minjae, et al.. (2024). Evaluation of Pregabalin bioadhesive multilayered microemulsion IOP-lowering eye drops. Journal of Controlled Release. 373. 667–687. 1 indexed citations
3.
4.
Zhang, Ying, et al.. (2023). Recent Advances in Visible‐Light‐Driven C−S Bond Formation. Advanced Synthesis & Catalysis. 365(20). 3413–3431. 36 indexed citations
5.
Hollingsworth, TJ, et al.. (2023). Current Advancements in Mouse Models of Retinal Disease. Advances in experimental medicine and biology. 1415. 371–376. 1 indexed citations
6.
Hollingsworth, TJ, et al.. (2022). Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration in a Spontaneous Polygenic Model of Inherited Retinal Dystrophy. Frontiers in Pharmacology. 13. 839424–839424. 4 indexed citations
7.
Hollingsworth, TJ, et al.. (2021). Proinflammatory Pathways Are Activated in the Human Q344X Rhodopsin Knock-In Mouse Model of Retinitis Pigmentosa. Biomolecules. 11(8). 1163–1163. 12 indexed citations
8.
Wang, XiangDi, et al.. (2020). Enhanced Corneal Penetration of a Poorly Permeable Drug Using Bioadhesive Multiple Microemulsion Technology. Pharmaceutics. 12(8). 704–704. 25 indexed citations
9.
Wang, XiangDi, Xiaofei Wang, Yunfeng Shi, et al.. (2019). NA3 glycan: a potential therapy for retinal pigment epithelial deficiency. FEBS Journal. 286(24). 4876–4888. 3 indexed citations
10.
Mishra, Sanjay R., et al.. (2019). Once Daily Pregabalin Eye Drops for Management of Glaucoma. ACS Nano. 13(12). 13728–13744. 32 indexed citations
11.
Tatke, Akshaya, Karthik Yadav Janga, Bharathi Avula, et al.. (2018). P-glycoprotein Restricts Ocular Penetration of Loperamide across the Blood-Ocular Barriers: a Comparative Study in Mdr1a Knock-out and Wild Type Sprague Dawley Rats. AAPS PharmSciTech. 19(4). 1662–1671. 7 indexed citations
12.
Janga, Karthik Yadav, Akshaya Tatke, Surabhi Shukla, et al.. (2018). Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide. Journal of Pharmaceutical Sciences. 107(8). 2128–2135. 9 indexed citations
13.
Patil, Renukadevi, Amira Hosni-Ahmed, Terreia S. Jones, et al.. (2014). Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents. Anti-Cancer Agents in Medicinal Chemistry. 14(3). 473–482. 5 indexed citations
14.
Wang, XiangDi, et al.. (2013). A crystallin gene network in the mouse retina. Experimental Eye Research. 116. 129–140. 24 indexed citations
15.
Wang, XiangDi, Renukadevi Patil, Shivaputra A. Patil, et al.. (2012). EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo. Anti-Cancer Drugs. 23(5). 494–504. 3 indexed citations
16.
Patil, Renukadevi, Shivaputra A. Patil, XiangDi Wang, et al.. (2010). Synthesis and evaluation of new 1,2,3,4-tetrahydroisoquinoline analogs as antiglioma agents. Medicinal Chemistry Research. 20(1). 131–137. 6 indexed citations
17.
Ma, Fei, Hari Kosanam, XiangDi Wang, et al.. (2009). Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL‐155, a novel antitumor agent for retinoblastoma in rats. Journal of Mass Spectrometry. 44(5). 786–793. 5 indexed citations
18.
Song, Pengfei, Fei Ma, Fan Wang, et al.. (2007). Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats. Cancer Chemotherapy and Pharmacology. 61(6). 1037–1044. 7 indexed citations
19.
Brown, Christina, et al.. (2007). The developmental regulation of CD81 in the rat retina.. PubMed. 13. 181–9. 9 indexed citations
20.
Yamada, Yoshihiro, XiangDi Wang, Shin‐ichiro Yokoyama, Noboru Fukuda, & Nobuyuki Takakura. (2006). Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochemical and Biophysical Research Communications. 342(2). 662–670. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Olkowska Breakdown of academic impact, for papers by Nicholas Watson Breakdown of academic impact, for papers by Wei‐Chung Vivian Yang Breakdown of academic impact, for papers by Yiwei Qi Breakdown of academic impact, for papers by Joanna Stachura Breakdown of academic impact, for papers by Jiahui Kong Breakdown of academic impact, for papers by Qianqian Shan Breakdown of academic impact, for papers by Imke Rudnik‐Jansen
Rankless by CCL
2026